0.8225  0.023 (2.84%)		10-23 16:00
Open: 0.8 High: 0.8494 Volume: 243,361		Pre. Close: 0.7998 Low: 0.7811 Market Cap: 18(M)

Short term
Mid term
Targets	6-month :	1.69	1-year :	2.2
Resists	First :	1.45	Second :	1.88
Pivot price	0.91
Supports	First :	0.74	Second :	0.61
MAs	MA(5) :	0.83	MA(20) :	0.87
	MA(100) :	1.29	MA(250) :	1.51
MACD	MACD :	-0.1	Signal :	-0.1
%K %D	K(14,3) :	6.8	D(3) :	8
RSI	RSI(14): 42.7
52-week	High :	3.08	Low :	0.74

Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.
[ COCH ] has closed above bottom band by 36.2%. Bollinger Bands are 77.3% wider than normal. The large width of the bands suggest high volatility as compared to its normal range. The bands have been in this wide range for 22 days. This is a sign that the current trend might continue.

If tomorrow:	Open lower	Open higher
High:	0.85 - 0.85	0.85 - 0.86
Low:	0.77 - 0.77	0.77 - 0.78
Close:	0.79 - 0.8	0.8 - 0.81

Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum. Its products include hearing aids; Esteem middle ear implants; bone conduction devices; and Acclaim cochlear implants. Envoy Medical Corporation was formerly known as St. Croix Medical, Inc. and changed its name to Envoy Medical Corporation in December 2004. The company was founded in 1995 and is based in White Bear Lake, Minnesota.

Thu, 23 Oct 2025
Envoy Medical to Present at the Virtual Technology Investor Conference on October 28th - The Manila Times

Mon, 20 Oct 2025
Bears are Losing Control Over Envoy Medical, Inc. (COCH), Here's Why It's a 'Buy' Now - Yahoo Finance

Thu, 09 Oct 2025
Envoy Medical Announces Closing of Up to $16 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules - Newsfile

Wed, 08 Oct 2025
Up to $16M funding — Envoy Medical raises $4.0M in registered direct offering with concurrent warrants - Stock Titan

Tue, 07 Oct 2025
EXCLUSIVE: Envoy Medical Cuts Capital Needs After FDA Approval For Final Trial Stage Of Cochlear Implant Trial - Sahm

Tue, 07 Oct 2025
FDA approves expansion of Envoy Medical’s cochlear implant trial - Investing.com

Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.	Underperform
Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).	Underperform
Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.	Underperform
Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.	Underperform
Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.	Outperform
Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.	Underperform

Exchange: NASDAQ
Sector: Healthcare
Industry: Medical - Devices
Shares Out	0 (M)
Shares Float	29 (M)
Held by Insiders	1.188e+007 (%)
Held by Institutions	37.1 (%)
Shares Short	301 (K)
Shares Short P.Month	0 (K)

EPS	-1.945e+007
EPS Est Next Qtrly	0
EPS Est This Year	0
EPS Est Next Year	0
Book Value (p.s.)	0
Profit Margin	0 %
Operating Margin	-6 %
Return on Assets (ttm)	500 %
Return on Equity (ttm)	-148 %
Qtrly Rev. Growth	222000 %
Gross Profit (p.s.)	7.1
Sales Per Share	0
EBITDA (p.s.)	-281159
Qtrly Earnings Growth	-1.5 %
Operating Cash Flow	0 (M)
Levered Free Cash Flow	-16 (M)

PE Ratio	-0.01
PEG Ratio	0
Price to Book value	0
Price to Sales	0
Price to Cash Flow	-1.21

Dividend	0
Forward Dividend	218930
Dividend Yield	0%
Dividend Pay Date	Invalid DateTime.
Ex-Dividend Date	Invalid DateTime.